DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Clinical trial NCT06645236 · RECRUITING

Trial details

NCT number: NCT06645236
Sponsor: QIAGEN Gaithersburg, Inc
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (mCRC)

Start date: 2023-12-22
Primary completion: 2030-10-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.